The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with GLP-1 drugs ...
The eye condition, known as non-arteritic anterior ischemic optic neuropathy, has been reported with all GLP-1 drugs. It can ...
What if you started taking a medication to manage diabetes or lose weight, only to learn it carries a potential risk of ...
The Food and Drug Administration now requires warning labels on Ozempic, Wegovy and other GLP-1 drugs over a rare eye condition tied to vision loss.
Learn how it works and who it could be a good fit for.
The FDA is requiring new warnings for GLP-1 drugs including Ozempic, Wegovy, Mounjaro and Zepbound over a potential increased ...
Eli Lilly’s latest weight loss drug candidate, retatrutide, is already being talked about as a potential game changer in obesity and diabetes care.
The Food and Drug Administration is requiring updated safety labels on all GLP-1 medications because of a possible link to a ...
WHEN YOU LOSE weight through traditional diet and exercise, you tend to see a gradual slimming down of your face. But when ...
Weight loss can ease foot pain, but it can also leave you with less cushioning and looser shoes. Added padding and a better ...
A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements for people with type 2 diabetes than the leading oral semaglutide in a major clinical ...
Lilly reports that retatrutide achieved greater weight loss and blood sugar reduction than Ozempic 2 mg in an 80-week type 2 diabetes trial.